Premium Information is available for this item - Upgrade for $1 a day
6505-01-260-7876
Usp Chlorprothixene Tablets
6505012607876 012607876 TARACTAN TABLETS 77824 NDC00004-0046-01
January 2023
5
Marketplace 6505-01-260-7876
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-260-7876 5+ Documents (More...)
Chlorprothixene 100.000 Tablets NATO Stock Numbers Related to 6505-01-209-0719 6505-01-209-0719 6505-01-260-7876
(Active) Primary Buy RNCC 3 RNVC 2 DAC 6 TARACTAN TABLETS 04493 - Hoffmann-La Roche Inc.
DAC: 4 2 Oct 2003 2950-00-816-0733 https//www.nsnlookup.com /cage Schlegel Systems Inc (CAGE Code 77824
) Rochester 6. 77824 Schlegel Systems Inc, Div Rochester Division is an Active Manufacturer with the
Restrictions 6505-01-260-7876
6505-01-260-7876 is a Usp Chlorprothixene Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-260-7876
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-260-7876
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-260-7876
- Part Number
- Manufacturer
- Status
- 77824
- Manufacturer
- 66002 - Roche Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00004-0046-01
- 66002 - Roche Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- TARACTAN TABLETS
- 66002 - Roche Laboratories Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-260-7876
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 25.000 Milligrams Chlorprothixene Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
NATO Stock Numbers Related to 6505-01-260-7876
Freight Information 6505-01-260-7876
6505-01-260-7876 has freight characteristics.. 6505-01-260-7876 has a variance between NMFC and UFC when transported by rail and the description should be consulted.